Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Freedom Photonics LLC	Solfice Research, Inc.	TPK Universal Solutions Limited	Equity Financing Program	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Freedom Photonics LLC	Additional Paid-in Capital Solfice Research, Inc.	Additional Paid-in Capital TPK Universal Solutions Limited	Additional Paid-in Capital Equity Financing Program	Accumulated Other Comprehensive Loss	Treasury Stock	Accumulated Deficit	Class A Common Stock	Class A Common Stock Equity Financing Program	Class A Common Stock Common Stock	Class A Common Stock Common Stock Freedom Photonics LLC	Class A Common Stock Common Stock Solfice Research, Inc.	Class A Common Stock Common Stock TPK Universal Solutions Limited	Class A Common Stock Common Stock Equity Financing Program	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2021																	266,076,525						97,088,670
Beginning balance at Dec. 31, 2021	$ 197,985						$ 1,257,214					$ (908)	$ (235,871)	$ (822,487)			$ 27						$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(76,606)												(76,606)
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)																	405,752
Issuance of Class A common stock upon exercise of Private Warrants	19,003						19,003
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)																	6,920,617
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	2,846						2,845										$ 1
Retirement of unvested restricted common stock (in shares)																	(48,204)
Retirement of unvested restricted common stock	0
Vendor payments under the stock-in-lieu of cash program (in shares)																	9,574,385
Vendor payments under the stock-in-lieu of cash program	60,678						60,677										$ 1
Optogration milestone awards (in shares)																	1,632,056
Optogration milestone awards	11,751						11,751
Consideration related to acquisitions (in shares)																		2,176,205	374,193
Consideration related to acquisitions		$ 30,510	$ 3,361					$ 30,510	$ 3,361
Share-based compensation	102,408						102,408
Payments of employee taxes related to stock-based awards	(2,773)						(2,773)
Other comprehensive income (loss)	(5,081)											(5,081)
Net loss	(301,122)													(301,122)
Ending balance (in shares) at Sep. 30, 2022																	287,111,529						97,088,670
Ending balance at Sep. 30, 2022	42,960						1,484,996					(5,989)	(312,477)	(1,123,609)			$ 29						$ 10
Beginning balance (in shares) at Jun. 30, 2022																	282,211,182						97,088,670
Beginning balance at Jun. 30, 2022	88,561						1,413,064					(6,005)	(312,477)	(1,006,059)			$ 28						$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)																	2,735,219
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	1,102						1,101										$ 1
Retirement of unvested restricted common stock (in shares)																	(4,648)
Retirement of unvested restricted common stock	0
Vendor payments under the stock-in-lieu of cash program (in shares)																	537,720
Vendor payments under the stock-in-lieu of cash program	16,920						16,920
Optogration milestone awards (in shares)																	1,632,056
Optogration milestone awards	11,751						11,751
Share-based compensation	43,209						43,209
Payments of employee taxes related to stock-based awards	(1,049)						(1,049)
Other comprehensive income (loss)	16											16
Net loss	(117,550)													(117,550)
Ending balance (in shares) at Sep. 30, 2022																	287,111,529						97,088,670
Ending balance at Sep. 30, 2022	42,960						1,484,996					(5,989)	(312,477)	(1,123,609)			$ 29						$ 10
Beginning balance (in shares) at Dec. 31, 2022																	291,942,087						97,088,670
Beginning balance at Dec. 31, 2022	(26,405)						1,558,685					(4,226)	(312,477)	(1,268,426)			$ 29						$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)																	13,414,078				5,599,121
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	2,553				$ 38,711		2,551				$ 38,711					$ 38,700	$ 2
Issuance of Class A common stock under employee stock purchase plan (ESPP) (in shares)																	272,524
Issuance of Class A common stock under employee stock purchase plan (“ESPP”)	1,406						1,406
Issuance of Class A common stock to Plus (in shares)						1,926,471
Issuance of Class A common stock to Plus	12,141						12,141
Vendor payments under the stock-in-lieu of cash program (in shares)																	6,505,012
Vendor payments under the stock-in-lieu of cash program	43,329						43,328										$ 1
Milestone related to acquisitions (in shares)																	2,943,401
Milestone awards related to acquisitions	20,656						20,656
Consideration related to acquisitions (in shares)																				3,305,784
Consideration related to acquisitions				$ 20,000						$ 20,000
Share-based compensation	141,393						141,393
Payments of employee taxes related to stock-based awards	(572)						(572)
Other comprehensive income (loss)	3,991											3,991
Net loss	(422,868)													(422,868)
Ending balance (in shares) at Sep. 30, 2023															304,045,028		325,908,478					97,088,670	97,088,670
Ending balance at Sep. 30, 2023	(165,665)						1,838,299					(235)	(312,477)	(1,691,294)			$ 32						$ 10
Beginning balance (in shares) at Jun. 30, 2023																	313,888,629						97,088,670
Beginning balance at Jun. 30, 2023	(129,147)						1,741,053					(808)	(312,477)	(1,556,956)			$ 31						$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)																	4,688,949			1,652,892	1,833,829
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	904			$ 10,000	$ 9,107		903			$ 10,000	$ 9,107					$ 9,100
Issuance of Class A common stock to Plus (in shares)						1,926,471
Issuance of Class A common stock to Plus	12,141						12,141
Vendor payments under the stock-in-lieu of cash program (in shares)																	389,920
Vendor payments under the stock-in-lieu of cash program	9,734						9,734
Milestone related to acquisitions (in shares)																	1,527,788
Milestone awards related to acquisitions	11,336						11,336
Share-based compensation	44,025						44,025
Other comprehensive income (loss)	573											573
Net loss	(134,338)													(134,338)
Ending balance (in shares) at Sep. 30, 2023															304,045,028		325,908,478					97,088,670	97,088,670
Ending balance at Sep. 30, 2023	$ (165,665)						$ 1,838,299					$ (235)	$ (312,477)	$ (1,691,294)			$ 32						$ 10